当前位置: 首页 > 溶液、染色液 > 特殊染色液 > Masson三色染色试剂盒

BP-DL021

Masson三色染色试剂盒

规格 50mL/100mL
  • 英文名:
  • Masson Staining Kit
  • CAS号:
  • 分子式:
  • 品牌:
  • Sbjbio
  • MDL:
  • 储存条件:
  • 室温,避光,12个月
产品编号 销售价促销价 库存 数量 单位 加入购物车
BP-DL021-50mL ¥280.00元 准现货 EA 加入购物车
BP-DL021-500mL ¥1400.00元 准现货 EA 加入购物车
BP-DL021-100mL ¥470.00元 准现货 EA 加入购物车

商品描述

文献引用

质检证书(COA)

相关商品

【货号】 BP-DL021

【规格】 7×50mL/7×100mL/7×500mL

【保存】 10~30℃,避光,12个月有效。

【产品组成】

 image.png

【产品简介】

结缔组织狭义上是指其含有的三种纤维:胶原纤维、网状纤维、弹力纤维,而胶原纤维(collagen fiber)是分布最广、含量最多的一种纤维。Masson三色染色又称马松染色,是结缔组织染色中最经典的一种方法,是胶原纤维染色权威而经典的技术方法。所谓三色染色通常是指染胞核和能选择性的显示胶原纤维和肌纤维。该法染色原理与阴离子染料分子的大小和组织的渗透有关:分子的大小由分子量来体现,小分子量易穿透结构致密、渗透性低的组织;而大分子量则只能进入结构疏松的、渗透性高的组织。然而,淡绿或苯胺蓝的分子量都很大,因此Masson染色后肌纤维呈红色,胶原纤维呈绿色(淡绿)或蓝色(苯胺蓝),主要用于区分胶原纤维和肌纤维。染色稳定;分化时间短,1~2s;色彩清晰鲜艳;适用范围广,适宜于组织的石蜡切片、冰冻切片等染色;所染切片保存时间长且不易褪色。

【使用方法】 

1、切片常规脱蜡至水,用配制好的Weigert铁苏木素染色5~10min。

2、用酸性乙醇分化液分化,水洗。

3、用Masson蓝化液返蓝,水洗。

4、蒸馏水洗1min。

5、丽春红品红染色液染色5~10min(镜下控制染色时间)。

6、蒸馏水稍洗。

7、磷钼酸溶液洗5~10min。

8、直接入苯胺蓝染色液中染色1~2min。

9、弱酸溶液洗1min。

10、95%乙醇快速脱水。无水乙醇脱水3次,每次5~10s。

11、二甲苯透明3次,每次1~2min。中性树胶封固。

【染色结果】

 

image.png

【注意事项】

1、切片脱蜡应尽量干净。固定起着重要的作用,使用不同的固定液可延或缩短染色时间。

2、取A1、A2等量混合即为Weigert铁苏木素染液,一般24h失去染色力。

3、酸性乙醇分化时间应根据切片厚薄、组织的类别和新旧而定。

4、弱酸溶液可使色彩更清晰鲜艳,如使用量大可自行配制0.1~0.3%乙酸溶液予以替代。

5、磷钼酸分化时要在镜下控制,分化到胶原纤维呈淡红色、纤维呈红色即可。分化时间根据染色深浅而定,一般1~2min。

6、Masson蓝化液亦可自行配制Scott促蓝液或0.1~1%碳酸锂水溶液予以替代。

 


1.Ma X, Ma X, Ma Z, et al. The effects of uygur herb Hyssopus officinalis L. on the process of airway remodeling in asthmatic mice[J]. Evidence-Based Complementary and Alternative Medicine, 2014, 2014.

2.Wang W, Hu J, He C, et al. Heparinized PLLA/PLCL nanofibrous scaffold for potential engineering of small‐diameter blood vessel: Tunable elasticity and anticoagulation property[J]. Journal of Biomedical Materials Research Part A, 2015, 103(5): 1784-1797.

3.Wang W, Hu J, He C, et al. Heparinized PLLA/PLCL nanofibrous scaffold for potential engineering of small‐diameter blood vessel: Tunable elasticity and anticoagulation property[J]. Journal of Biomedical Materials Research Part A, 2015, 103(5): 1784-1797.

4.Wu C, Dong S, Li Y. Effects of miRNA-455 on cardiac hypertrophy induced by pressure overload[J]. International journal of molecular medicine, 2015, 35(4): 893-900.

5.Ren Z, Wang Y, Ma S, et al. Effective bone regeneration using thermosensitive poly (N-isopropylacrylamide) grafted gelatin as injectable carrier for bone mesenchymal stem cells[J]. ACS applied materials & interfaces, 2015, 7(34): 19006-19015.

6.Duan S, Yang X, Mei F, et al. Enhanced osteogenic differentiation of mesenchymal stem cells on poly (l‐lactide) nanofibrous scaffolds containing carbon nanomaterials[J]. Journal of Biomedical Materials Research Part A, 2015, 103(4): 1424-1435.

2.Ruan J, Wang X, Yu Z, et al. Enhanced Physiochemical and Mechanical Performance of Chitosan‐Grafted Graphene Oxide for Superior Osteoinductivity[J]. Advanced Functional Materials, 2016, 26(7): 1085-1097.

7.Jin J, Lv R, Guo J, et al. Improvement of left ventricular remodelling by inhibition of NF-κB in a rat model of myocardial infarction[J]. Heart, Lung and Circulation, 2016, 25(10): 1007-1012.

8.Jia Y, Wang W, Zhou X, et al. Synthesis and characterization of poly (glycerol sebacate)-based elastomeric copolyesters for tissue engineering applications[J]. Polymer Chemistry, 2016, 7(14): 2553-2564.

9.Xiao T, Luo J, Wu Z, et al. Effects of hydrogen sulfide on myocardial fibrosis and PI3K/AKT1-regulated autophagy in diabetic rats[J]. Molecular medicine reports, 2016, 13(2): 1765-1773.

10.Chi Y C, Shi C L, Zhou M, et al. Selective cyclooxygenase-2 inhibitor NS-398 attenuates myocardial fibrosis in mice after myocardial infarction via Snail signaling pathway[J]. Eur Rev Med Pharmacol Sci, 2017, 21(24): 5805-5812.

11.Ren Z, Ma S, Jin L, et al. Repairing a bone defect with a three-dimensional cellular construct composed of a multi-layered cell sheet on electrospun mesh[J]. Biofabrication, 2017, 9(2): 025036.

12.Liang B, Xiao T, Long J, et al. Hydrogen sulfide alleviates myocardial fibrosis in mice with alcoholic cardiomyopathy by downregulating autophagy[J]. International journal of molecular medicine, 2017, 40(6): 1781-1791.

13.Zhang Z, Li Z, Cao K, et al. Adjunctive therapy with statins reduces residual albuminuria/proteinuria and provides further renoprotection by downregulating the angiotensin II–AT1 pathway in hypertensive nephropathy[J]. Journal of hypertension, 2017, 35(7): 1442-1456.

14.Gong Z, Tang J, Xiang T, et al. Genome‑wide identification of long noncoding RNAs in CCl4‑induced liver fibrosis via RNA sequencing[J]. Molecular medicine reports, 2018, 18(1): 299-307.

15.Hou H T, Wang Y N, Shao S Z, et al. High calcium diet alleviates 5/6 nephrectomy-induced bone deteriorations of lumbar vertebrae in mice[J]. Experimental and therapeutic medicine, 2018, 15(4): 3483-3488.

16.Tang B, Zhang J G, Tan H Y, et al. Astragaloside IV inhibits ventricular remodeling and improves fatty acid utilization in rats with chronic heart failure[J]. Bioscience reports, 2018, 38(3).

17.Liu R, Zhang H B, Yang J, et al. Curcumin alleviates isoproterenol-induced cardiac hypertrophy and fibrosis through inhibition of autophagy and activation of mTOR[J]. European review for medical and pharmacological sciences, 2018, 22(21): 7500-7508.

18.Gong Z, Lin J, Zheng J, et al. Dahuang Zhechong pill attenuates CCl4‐induced rat liver fibrosis via the PI3K‐Akt signaling pathway[J]. Journal of cellular biochemistry, 2019.

19.Zhang W X, Tai G J, Li X X, et al. Inhibition of neointima hyperplasia by the combined therapy of linagliptin and metformin via AMPK/Nox4 signaling in diabetic rats[J]. Free Radical Biology and Medicine, 2019, 143: 153-163.

20.Deng Y, Guo S, Wei B, et al. Activation of nicotinic acetylcholine α7 receptor attenuates progression of monocrotaline-induced pulmonary hypertension in Rats by downregulating the NLRP3 inflammasome[J]. Frontiers in Pharmacology, 2019, 10: 128.

21.Lin J, Deng C, Peng Y, et al. Dynamic Changes in MMP1 and TIMP1 in the Antifibrotic Process of Dahuang Zhechong Pill in Rats with Liver Fibrosis[J]. Open Chemistry, 2019, 17(1): 346-356.

22.Yuan Z, Wei P, Huang Y, et al. Injectable PLGA microspheres with tunable magnesium ion release for promoting bone regeneration[J]. Acta biomaterialia, 2019, 85: 294-309.

23.Wei P, Jing W, Yuan Z, et al. Vancomycin-and Strontium-Loaded Microspheres with Multifunctional Activities against Bacteria, in Angiogenesis, and in Osteogenesis for Enhancing Infected Bone Regeneration[J]. ACS applied materials & interfaces, 2019, 11(34): 30596-30609.

24.Wei P, Yuan Z, Jing W, et al. Strengthening the potential of biomineralized microspheres in enhancing osteogenesis via incorporating alendronate[J]. Chemical Engineering Journal, 2019, 368: 577-588.

25.Zhou C, Li C, Wang Q, et al. Histopathological and proteomic analyses identify integrin-β1 as a potential mediator of phlebosclerosis in uremic patients[J]. Clinical and Experimental Nephrology, 2019: 1-9.

26.Shi A, Heinayati A, Bao D, et al. Small molecule inhibitor of TGF-β signaling enables robust osteogenesis of autologous GMSCs to successfully repair minipig severe maxillofacial bone defects[J]. Stem cell research & therapy, 2019, 10(1): 172.